Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study
Suzuki, Motoi, MD, Dhoubhadel, Bhim Gopal, PhD, Ishifuji, Tomoko, MD, Yasunami, Michio, MD, Yaegashi, Makito, MD, Asoh, Norichika, MD, Ishida, Masayuki, MD, Hamaguchi, Sugihiro, MD, Aoshima, Masahiro, MD, Ariyoshi, Koya, Prof, Morimoto, Konosuke, Dr
Published in The Lancet infectious diseases (01.03.2017)
Published in The Lancet infectious diseases (01.03.2017)
Get full text
Journal Article